Patient Advocacy Summit 2019

November 6, 2019 8:00 AM - 4:30 PM

Marriott Boston Cambridge, 50 Broadway, Cambridge, Massachusetts 02142 USA

Add to Calendar 11/6/2019 8:00:00 AM 11/6/2019 4:30:00 PM Patient Advocacy Summit 2019

MassBio's Patient Advocacy Summit brings together the patient advocacy community to showcase best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do—not just approaching regulatory applications or at commercialization, but throughout the drug development cycle.

This year we'll explore competing views on what value therapies bring to various stakeholders, what a cure is worth to patients and society, how to improve the clinical trial experience for patients, and more. We will also have a frank discussion about patient access in the era of transformative therapies, and you’ll hear directly from patients on what this means to them.

The program includes panel discussions, case study presentations(spotlighting industry/patient partnerships), an inspirational keynote address, as well as a networking lunch and cocktail reception.

See sponsorship opportunities here, or contact Laura Rudberg.

 Marriott Boston Cambridge, 50 Broadway, Cambridge, Massachusetts 02142 USA
VP, Head of Rare Disease Divsion, Biogen
Matt is committed to the development and commercialization of innovative therapies for rare and hard to treat neurological diseases Matt has spent more than 5 years at Biogen now. Since February 2018, He has served as VP, head of the Rare Disease Division. Prior to that Matt was Sr. Director, Chief of Staff to the Global CEO Michel Vounatsos. He also worked in Payer and Channel Marketing for both the Rare Disease and MS Franchises while at Biogen. Matt worked in Life Science Consulting prior to coming to Biogen at a number of different companies. He worked on projects with small biotech as well as large pharmaceutical companies.

Brought to you by